MXPA02011436A - Composiciones farmaceuticas micelares para aplicacion bucal y pulmonar. - Google Patents
Composiciones farmaceuticas micelares para aplicacion bucal y pulmonar.Info
- Publication number
- MXPA02011436A MXPA02011436A MXPA02011436A MXPA02011436A MXPA02011436A MX PA02011436 A MXPA02011436 A MX PA02011436A MX PA02011436 A MXPA02011436 A MX PA02011436A MX PA02011436 A MXPA02011436 A MX PA02011436A MX PA02011436 A MXPA02011436 A MX PA02011436A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- buccal
- pulmonary application
- disclosed
- micellar pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se describen composiciones farmacéuticas que comprenden un agente farmacéutico macromolecular en forma micelar mixta. Las micelas mixtas se forman a partir de un alquil sulfato de metal alcalino y por lo menos tres diferentes compuestos formadores de micela como se describe en la especificacion. El tamaño de micela varía de entre aproximadamente 1 y 10 nanometros. También se describen métodos para hacer y utilizar las composiciones. Un método preferido para administrar la composicion de la presente es a través de la region bucal de la boca.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/574,504 US6451286B1 (en) | 1998-12-21 | 2000-05-19 | Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
PCT/CA2001/000661 WO2001087268A1 (en) | 2000-05-19 | 2001-05-07 | Micellar pharmaceutical compositions for buccal and pulmonary application |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02011436A true MXPA02011436A (es) | 2003-06-06 |
Family
ID=24296427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02011436A MXPA02011436A (es) | 2000-05-19 | 2001-05-07 | Composiciones farmaceuticas micelares para aplicacion bucal y pulmonar. |
Country Status (8)
Country | Link |
---|---|
US (1) | US6451286B1 (es) |
EP (1) | EP1296648A1 (es) |
JP (2) | JP2003533469A (es) |
AU (1) | AU2001258112A1 (es) |
CA (1) | CA2410065C (es) |
MX (1) | MXPA02011436A (es) |
NZ (1) | NZ522524A (es) |
WO (1) | WO2001087268A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
US6849263B2 (en) * | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
DE10007771A1 (de) * | 2000-02-14 | 2001-08-23 | Kleine & Steube Entoxin Gmbh | Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
GB2405338B (en) * | 2002-05-21 | 2006-04-12 | Anadis Ltd | Composition comprising antibodies for the prophylaxis of respiratory infections |
EP1369113B1 (en) * | 2002-06-06 | 2006-11-22 | CHIESI FARMACEUTICI S.p.A. | Solubilisation of drugs in HFA propellant by means of emulsions |
US20050238632A1 (en) * | 2004-04-23 | 2005-10-27 | Alburty David S | Propellant formulations |
DK1758590T3 (da) * | 2004-05-19 | 2011-11-21 | Los Angeles Biomed Res Inst | Anvendelse af et detergent til ikke-kirurgisk fjernelse af fedt |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
US20080103746A1 (en) | 2005-11-30 | 2008-05-01 | Searete Llc, A Limited Liability Corporation | Systems and methods for pathogen detection and response |
US7974856B2 (en) | 2005-11-30 | 2011-07-05 | The Invention Science Fund I, Llc | Computational systems and methods related to nutraceuticals |
US7827042B2 (en) | 2005-11-30 | 2010-11-02 | The Invention Science Fund I, Inc | Methods and systems related to transmission of nutraceutical associated information |
AP2008004447A0 (en) * | 2005-11-30 | 2008-04-30 | Generex Pharm Inc | Orally absorbed pharmaceutical formulation and method of administration |
US10296720B2 (en) | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
US8000981B2 (en) | 2005-11-30 | 2011-08-16 | The Invention Science Fund I, Llc | Methods and systems related to receiving nutraceutical associated information |
US8340944B2 (en) | 2005-11-30 | 2012-12-25 | The Invention Science Fund I, Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US7927787B2 (en) | 2006-06-28 | 2011-04-19 | The Invention Science Fund I, Llc | Methods and systems for analysis of nutraceutical associated components |
US8297028B2 (en) | 2006-06-14 | 2012-10-30 | The Invention Science Fund I, Llc | Individualized pharmaceutical selection and packaging |
GB0621707D0 (en) * | 2006-10-31 | 2006-12-13 | Univ London Pharmacy | Formulations for delivery via pressurised metered dose inhalers |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
FR2947729B1 (fr) * | 2009-07-10 | 2012-01-20 | Philippe Perovitch | Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale |
EP2504019A2 (en) | 2009-11-25 | 2012-10-03 | ArisGen SA | Mucosal delivery composition comprising a peptide complexed with a crown compound and/or a counter ion |
EP3708190A1 (en) | 2010-02-26 | 2020-09-16 | Novo Nordisk A/S | Stable antibody containing compositions |
US20130136733A1 (en) * | 2010-05-28 | 2013-05-30 | Novo Nordisk A/S | Stable Multi-Dose Compositions Comprising an Antibody and a Preservative |
US20120237492A1 (en) | 2011-02-18 | 2012-09-20 | Kythera Biopharmaceuticals, Inc. | Treatment of submental fat |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
EP2526971A1 (en) | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
US20180314240A1 (en) * | 2017-04-28 | 2018-11-01 | Honeywell International Inc. | Flexible hierarchical model for monitoring distributed industrial control systems |
US10076484B1 (en) | 2017-05-01 | 2018-09-18 | Robert Baron | Formulation and method of conditioning skin and preserving cosmetics applied thereto |
CN110105385A (zh) * | 2019-04-09 | 2019-08-09 | 山东天力能源股份有限公司 | 一种海参废液综合性利用工艺 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53107408A (en) | 1977-02-28 | 1978-09-19 | Yamanouchi Pharmaceut Co Ltd | Micellar preparation for rectal infusion |
NL193099C (nl) | 1981-10-30 | 1998-11-03 | Novo Industri As | Gestabiliseerde insuline-oplossing. |
EP0158441B2 (en) | 1984-03-08 | 2001-04-04 | Phares Pharmaceutical Research N.V. | Liposome-forming composition |
DK179286D0 (da) | 1986-04-18 | 1986-04-18 | Nordisk Gentofte | Insulinpraeparat |
US5690954A (en) | 1987-05-22 | 1997-11-25 | Danbiosyst Uk Limited | Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material |
US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
CA2033725C (en) | 1990-01-24 | 2001-05-29 | Folker Pittrof | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid |
US5230884A (en) | 1990-09-11 | 1993-07-27 | University Of Wales College Of Cardiff | Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
US5292499A (en) | 1990-09-11 | 1994-03-08 | University Of Wales College Of Cardiff | Method of preparing medical aerosol formulations including drug dissolved in reverse micelles |
GB9202464D0 (en) | 1992-02-05 | 1992-03-18 | Danbiosyst Uk | Composition for nasal administration |
IT1255449B (it) | 1992-06-30 | 1995-10-31 | Fabio Berlati | Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci. |
US5653987A (en) | 1995-05-16 | 1997-08-05 | Modi; Pankaj | Liquid formulations for proteinic pharmaceuticals |
WO1996040057A2 (en) | 1995-06-07 | 1996-12-19 | Alliance Pharmaceutical Corp. | Reverse fluorocarbon emulsion compositions for drug delivery |
US5891465A (en) | 1996-05-14 | 1999-04-06 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
US6214375B1 (en) * | 1996-07-16 | 2001-04-10 | Generex Pharmaceuticals, Inc. | Phospholipid formulations |
AU4894697A (en) | 1997-10-01 | 1999-04-23 | Flemington Pharmaceutical Corporation | Buccal, polar and non-polar spray or capsule |
IL122084A (en) | 1997-10-31 | 1999-09-22 | Lurident Ltd | Formulation for personal care with mucoadhesive properties |
US6017545A (en) | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation |
US6221378B1 (en) * | 1998-02-10 | 2001-04-24 | Generex Pharmaceuticals Incorporated | Mixed micellar delivery system and method of preparation |
US6290987B1 (en) | 1998-09-27 | 2001-09-18 | Generex Pharmaceuticals, Inc. | Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids |
US6193997B1 (en) * | 1998-09-27 | 2001-02-27 | Generex Pharmaceuticals Inc. | Proteinic drug delivery system using membrane mimetics |
US6312665B1 (en) | 1998-12-21 | 2001-11-06 | Generex Pharmaceuticals Incorporated | Aerosol formulations for buccal and pulmonary application |
US6271200B1 (en) * | 1998-12-21 | 2001-08-07 | Generex Pharmaceuticals Inc. | Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
AU2879100A (en) | 1999-02-12 | 2000-08-29 | Miles A. Libbey Iii | Formulation and system for intra-oral delivery of pharmaceutical agents |
CA2364610C (en) | 1999-03-19 | 2006-12-19 | Generex Pharmaceuticals Inc. | Pharmaceutical solubilized in aerosol propellant |
-
2000
- 2000-05-19 US US09/574,504 patent/US6451286B1/en not_active Expired - Fee Related
-
2001
- 2001-05-07 WO PCT/CA2001/000661 patent/WO2001087268A1/en active IP Right Grant
- 2001-05-07 EP EP01931281A patent/EP1296648A1/en not_active Withdrawn
- 2001-05-07 AU AU2001258112A patent/AU2001258112A1/en not_active Abandoned
- 2001-05-07 MX MXPA02011436A patent/MXPA02011436A/es active IP Right Grant
- 2001-05-07 CA CA002410065A patent/CA2410065C/en not_active Expired - Fee Related
- 2001-05-07 JP JP2001583737A patent/JP2003533469A/ja active Pending
- 2001-05-07 NZ NZ522524A patent/NZ522524A/en not_active IP Right Cessation
-
2011
- 2011-07-19 JP JP2011157744A patent/JP2012006934A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2410065C (en) | 2009-04-07 |
WO2001087268A1 (en) | 2001-11-22 |
JP2003533469A (ja) | 2003-11-11 |
JP2012006934A (ja) | 2012-01-12 |
US6451286B1 (en) | 2002-09-17 |
CA2410065A1 (en) | 2001-11-22 |
EP1296648A1 (en) | 2003-04-02 |
AU2001258112A1 (en) | 2001-11-26 |
NZ522524A (en) | 2003-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02011436A (es) | Composiciones farmaceuticas micelares para aplicacion bucal y pulmonar. | |
WO2001066085A3 (en) | Micellar pharmaceutical compositions for buccal and pulmonary application | |
WO2004016244A3 (en) | Pharmaceutical compositions for buccal delivery of pain relief medications | |
ATE243498T1 (de) | Aerosol formulierungen für buccale und pulmonale anwendung | |
RS50008B (sr) | Antifungalna oralna kompozicija koja sadrži itrakonazol i postupak za dobijanje iste | |
GEP20022851B (en) | Flash-Melt Oral Dosage Formulation | |
TWI256891B (en) | 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations | |
WO2004016243A3 (en) | Methods of administering and enhancing absorption of pharmaceutical agents | |
ZA200601285B (en) | Pharmaceutical compositions containing drospirenone | |
MXPA04000226A (es) | Composiciones generadoras de mousse que contienen agentes de amonio cuaternario. | |
DE60139087D1 (de) | Verfahren zu Herstellung von Zubereitungen enthaltend einen Steroidhormon und ein Stabilisierungsmittel in nicht-kristallinen Form | |
WO2002080976A3 (en) | Hsa-free formulations of interferon-beta | |
EP1422217A3 (en) | Aminocyclohexyl ether compounds and uses thereof | |
WO2007074472A3 (en) | Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide | |
JP2003521570A (ja) | N−アシルアミノ酸および/または塩を含む安定な高グリセロール液 | |
CA2419314A1 (en) | Preparation of risperidone | |
HUT72594A (en) | New prednisolone derivative, process for its production, pharmaceutical composition containing the same | |
MXPA04001968A (es) | Agentes antidiabeticos. | |
MY137846A (en) | Processes for the preparation of oral dosage formulations of modafinil | |
WO2000054763A3 (en) | Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone | |
WO2001072278A3 (en) | Method for administering insulin to the buccal region | |
EP1157617A3 (en) | Use of alpha-keto enamine derivatives as ingredients | |
WO2002055062A3 (en) | Pharmaceutical tablet comprising paroxetine mesylate | |
HUT70961A (en) | Pharmaceutical compositions containing gemfibrozyl and process for producing them | |
WO2002011668A3 (en) | 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |